CLINICAL RESEARCH IN ASIA PACIFIC

ClinActis Asia Pacific CRO

WHY ASIA PACIFIC?

ASIA PACIFIC, RAPID GROWTH

Economic growth remains strong in Asia Pacific markets despite the current economic crisis ... see more

GOOD CLINICAL INFRASTRUCTURE

There is continuous growth in the scientific base and capabilities in Asia, encouraged by local authorities ...see more

EFFICIENT REGULATORY AND ETHICS COMMITEE PROCESSES

With the appropriate approach, the regulatory approval processes in most Asia is no more complex than in the US or Europe ...see more

ICH GCP AS THE ONLY STANDARD

Many countries adhere to ICH GCP in their processes for EC committee submission and regulatory approval ...see more

FASTER PATIENT RECRUITMENT AND HIGH RETENTION

Asia offers a large and diverse patient pool, with nearly 60% of the world population living in the region ...see more

COST BENEFITS

Including investigator sites in Asia can help reduce the overall drug development timelines ...see more

IP AND LEGAL

IP protection in Asia remains an issue when compared to Western standards. However, there has been significant progress ...see more

LOGISTICS

There are strict customs regulations within each country to comply with. Strategies to deal with ...see more

© 2020 by ClinActis Pte. Ltd. All rights reserved. 

36 Robinson Road,

City House, #12-06,

Singapore 068877

info@clinactis.com

Tel: +65 6436 5500